In this study, MTHFR gene mutation was associated with low risk for thrombosis in ET patients with odds ratio equal to 0.595, (P=0.1) which is in accordance with the study of Trifa et al. [19]. The gene discussed is MTHFR; the disease is essential thrombocythemia.